Literature DB >> 8940198

Limited proteolysis of human alpha2-HS glycoprotein/fetuin. Evidence that a chymotryptic activity can release the connecting peptide.

P Nawratil1, S Lenzen, J Kellermann, H Haupt, T Schinke, W Müller-Esterl, W Jahnen-Dechent.   

Abstract

alpha2-HS glycoprotein is a major protein of human plasma whose function is still obscure. A proteolytically processed form of alpha2-HS glycoprotein lacking a segment of 40 amino acid residues bridging its heavy and light chain portions ("connecting peptide") has been described suggesting that this peptide is released by post-translational processing to fulfill biological role(s) of alpha2-HS glycoprotein. To test this hypothesis we investigated how the connecting peptide is released from the parental molecule by limited proteolysis. We developed monoclonal antibodies to various portions of the connecting peptide and its NH2-terminal flanking region which cross-react with the native alpha2-HS glycoprotein. Purified alpha2-HS glycoprotein from human plasma was subjected to limited proteolysis by proteinases including trypsin, chymotrypsin, elastase plasmin, kallikrein, thrombin, and renin. Immunoprint analysis of the proteolytic digests indicated that alpha2-HS glycoprotein is readily cleaved in its connecting peptide region. NH2-terminal amino sequence analysis of the generated fragments demonstrated that a single proteinase, chymotrypsin, cleaves the critical Leu-Leu bond flanking the NH2-terminal portion of the connecting peptide region. Most but not all of the other proteinase cleavage sites map to a short stretch of 9 residues located in the center portion of the connecting peptide region. Immunoprint analysis of plasma samples from patients with sepsis demonstrate that the connecting peptide region is cleaved under pathological conditions. Our results indicate that the connecting peptide and/or fragments thereof are readily releasable from alpha2-HS glycoprotein in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940198     DOI: 10.1074/jbc.271.49.31735

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Phosphorylation of human plasma alpha2-Heremans-Schmid glycoprotein (human fetuin) in vivo.

Authors:  A C Haglund ; B Ek; P Ek
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment.

Authors:  Antonio Scollato; Alessandro Terreni; Anna Caldini; Benedetta Salvadori; Pasquale Gallina; Simona Francese; Guido Mastrobuoni; Giuseppe Pieraccini; Gloriano Moneti; Luca Bini; Gianni Messeri; Nicola Di Lorenzo
Journal:  Neurol Sci       Date:  2009-11-21       Impact factor: 3.307

3.  Association of alpha2-HS glycoprotein (AHSG, fetuin-A) polymorphism with AHSG and phosphate serum levels.

Authors:  Motoki Osawa; Wei Tian; Hidekazu Horiuchi; Mika Kaneko; Kazuo Umetsu
Journal:  Hum Genet       Date:  2004-12-09       Impact factor: 4.132

4.  All-atom ensemble modeling to analyze small-angle x-ray scattering of glycosylated proteins.

Authors:  Miklos Guttman; Patrick Weinkam; Andrej Sali; Kelly K Lee
Journal:  Structure       Date:  2013-03-05       Impact factor: 5.006

5.  Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A.

Authors:  Bernd Denecke; Steffen Gräber; Cora Schäfer; Alexander Heiss; Michael Wöltje; Willi Jahnen-Dechent
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

6.  Glycoproteogenomics: A Frequent Gene Polymorphism Affects the Glycosylation Pattern of the Human Serum Fetuin/α-2-HS-Glycoprotein.

Authors:  Yu-Hsien Lin; Jing Zhu; Sander Meijer; Vojtech Franc; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2019-05-16       Impact factor: 5.911

7.  Fetuin-A protein distribution in mature inflamed and ischemic brain tissue.

Authors:  Miriam Christina Heinen; Anne Babler; Joachim Weis; Johannes Elsas; Kay Nolte; Markus Kipp; Willi Jahnen-Dechent; Martin Häusler
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

8.  Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases.

Authors:  Konstantin Karmilin; Carlo Schmitz; Michael Kuske; Hagen Körschgen; Mario Olf; Katharina Meyer; André Hildebrand; Matthias Felten; Sven Fridrich; Irene Yiallouros; Christoph Becker-Pauly; Ralf Weiskirchen; Willi Jahnen-Dechent; Julia Floehr; Walter Stöcker
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

9.  Urinary fetuin-A peptides as a new marker for impaired kidney function in patients with type 2 diabetes.

Authors:  Pedro Magalhães; Petra Zürbig; Harald Mischak; Erwin Schleicher
Journal:  Clin Kidney J       Date:  2020-10-23

10.  Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.

Authors:  Kun Jia; Wei Li; Feng Wang; Haixia Qu; Yuanyuan Qiao; Lanping Zhou; Yulin Sun; Qingwei Ma; Xiaohang Zhao
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.